ALCOHOL-CONSUMPTION AND MORTALITY AMONG WOMEN

Citation
Cs. Fuchs et al., ALCOHOL-CONSUMPTION AND MORTALITY AMONG WOMEN, The New England journal of medicine, 332(19), 1995, pp. 1245-1250
Citations number
44
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00284793
Volume
332
Issue
19
Year of publication
1995
Pages
1245 - 1250
Database
ISI
SICI code
0028-4793(1995)332:19<1245:AAMAW>2.0.ZU;2-#
Abstract
Background. Studies in men suggest that light-to-moderate alcohol inta ke is associated with a reduction in overall mortality, due primarily to a reduced risk of coronary heart disease. Among women with similar levels of alcohol consumption, an increased risk of breast cancer has been noted that complicates the balance of risks and benefits. Methods . We conducted a prospective study among 85,709 women, 34 to 59 years of age and without a history of myocardial infarction, angina, stroke, or cancer, who completed a dietary questionnaire in 1980. During the 12-year follow-up period, 2658 deaths were documented. Results. The re lative risks of death in drinkers as compared with nondrinkers were 0. 83 (95 percent confidence interval, 0.74 to 0.93) for women who consum ed 1.5 to 4.9 g of alcohol per day (one to three drinks per week), 0.8 8 (95 percent confidence interval, 0.80 to 0.98) for those who consume d 5.0 to 29.9 g per day, and 1.19 (95 percent confidence interval, 1.0 2 to 1.38) for those who consumed 30 g or more per day, after adjustme nt for other predictors of mortality. Light-to-moderate drinking (1.5 to 29.9 g per day) was associated with a decreased risk of death from cardiovascular disease; heavier drinking was associated with an increa sed risk of death from other causes, particularly breast cancer and ci rrhosis. The benefit associated with light-to-moderate drinking was mo st apparent among women with risk factors for coronary heart disease a nd those 50 years of age or older. Conclusions. Among women, light-to- moderate alcohol consumption is associated with a reduced mortality ra te, but this apparent survival benefit appears largely confined to wom en at greater risk for coronary heart disease.